Jeff Yass’s Journey Medical DERM Stock Holding History

Jeff Yass’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Buy	20,001 +7,280	+57%	+$41.6K	﹤0.01%	12251
2026 Q1	$59.7K	Buy	12,721 +472	+4%	+$3.66K	﹤0.01%	12584
2025 Q4	$94.4K	Buy	+12,249	New	+$96K	﹤0.01%	11486
2025 Q3	–	Sell	-15,388	Closed	-$110K	–	12651
2025 Q2	$110K	Sell	15,388 -41,951	-73%	-$290K	﹤0.01%	11728
2025 Q1	$338K	Buy	57,339 +38,617	+206%	+$190K	﹤0.01%	9792
2024 Q4	$73.2K	Buy	+18,722	New	+$102K	﹤0.01%	11515
2022 Q4	–	Sell	-22,094	Closed	-$54K	–	12638
2022 Q3	$54K	Buy	+22,094	New	+$75.3K	﹤0.01%	12146

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Jeff Yass's DERM Position: Q2 2026 in Review

Jeff Yass increased its Journey Medical (DERM) stake by 57% in Q2 2026, buying an estimated $41.6K and bringing the position to 20,001 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #12251.

Jeff Yass first reported a position in DERM in Q3 2022 and has held it in 7 quarters since. The position peaked at $338K in Q1 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Jeff Yass held 20,001 shares of Journey Medical worth $142K as of Q2 2026.
Jeff Yass bought 7,280 Journey Medical shares in Q2 2026, an estimated $41.6K.
Journey Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12251 holding.
Jeff Yass first reported a position in Journey Medical in Q3 2022 and has held it in 7 quarters since.
Jeff Yass's Journey Medical position peaked at $338K in Q1 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.